ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 158 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $112,649 | -60.2% | 48,347 | -23.7% | 0.00% | -57.1% |
| Q1 2024 | $283,349 | +144.9% | 63,389 | +75.9% | 0.01% | +133.3% |
| Q4 2023 | $115,688 | +35.7% | 36,040 | +34.0% | 0.00% | +50.0% |
| Q3 2023 | $85,276 | -31.2% | 26,901 | +7.9% | 0.00% | -33.3% |
| Q2 2023 | $123,937 | – | 24,937 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $4,189,720 | 4.58% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 689,912 | $1,607,495 | 2.03% |
| Lynx1 Capital Management LP | 2,228,295 | $5,191,927 | 1.87% |
| Wildcat Capital Management, LLC | 2,920,787 | $6,805,434 | 1.66% |
| TPG GP A, LLC | 18,716,306 | $43,608,993 | 1.00% |
| Boxer Capital, LLC | 3,850,000 | $8,970,500 | 0.47% |
| Vestal Point Capital, LP | 2,200,000 | $5,126,000 | 0.38% |
| DAFNA Capital Management LLC | 605,100 | $1,409,883 | 0.34% |
| Frazier Life Sciences Management, L.P. | 2,867,750 | $6,681,858 | 0.31% |
| Coastal Bridge Advisors, LLC | 406,847 | $947,954 | 0.24% |